A Study of Ivonescimab in People With Leiomyosarcoma | MicrobiomeTrials← Back to trialsNCT07516925
A Study of Ivonescimab in People With Leiomyosarcoma
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-04-01Est. Completion: 2029-04
Enrollment target: 20 participants Locations- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre, New York, United States
Other microbiome trials you might be interested in
Solid TumorSarcomaLeiomyosarcomaDedifferentiated Liposarcoma
This early phase oncology trial will be conducted at various study centers to investigate the safety, tolerability, and …
San Francisco, United StatesEst. completion Dec 29, 2027
Metastatic Dedifferentiated LiposarcomaMetastatic LeiomyosarcomaMetastatic MyxofibrosarcomaMetastatic Sarcoma
Metastatic Synovial Sarcoma
Metastatic Undifferentiated Pleomorphic Sarcoma
Unresectable Dedifferentiated Liposarcoma
Unresectable Leiomyosarcoma
Unresectable Myxofibrosarcoma
Unresectable Sarcoma
Unresectable Synovial Sarcoma
Unresectable Undifferentiated Pleomorphic Sarcoma
This phase I trial tests the safety, side effects, and best dose of combination therapy with liposomal doxorubicin and p…
Los Angeles, United StatesEst. completion Nov 3, 2026